Viscovery and Biomax are introducing an analysis pipeline for longitudinal brain morphometry studies

[News Viscovery]

Munich (DE) / Vienna (AT), 7 June 2022 Viscovery and Biomax are introducing an analysis pipeline for longitudinal brain morphometry studies

Together with our colleagues from Biomax Informatics, we published the article Automated High-Definition MRI Processing Routine Robustly Detects Longitudinal Morphometry Changes in Alzheimer’s Disease Patients in Frontiers in Aging Neuroscience.

In this article a profound analysis pipeline for longitudinal MRI studies is proposed. It uses state-of-the-art methods for neuro-imaging, segmentation and statistical assessments. A case study with Alzheimer’s disease patients and a control group of age-related cognitively normal subjects from the ADNI-3 study was conducted to test the pipeline which was fully implemented in Biomax’ neuro-imaging solution NICARA.

Find the full open access article at www.frontiersin.org.